BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden
Federico Emanuele Pozzi,Luisa Calì,Fabrizia D'Antonio,Arianna Ida Altomare,Micaela Sepe Monti,Massimiliano Panigutti,Adolfo Di Crosta,Rocco Palumbo,Laura Bonanni,Valentina Carlucci,Cinzia Bussè,Annachiara Cagning,Daniele Urso,Davide Vilella,Giancarlo Logroscino,Margherita Alberoni,Angelo Bellinvia,Elisabetta Farina,Francesca de Rino,Armando Gavazzi,Marta Zuffi,Giuseppe Bruno,Valentina Bessi,Matteo Cotta Ramusino,Giulia Perini,Alfredo Costa,Carlo Ferrarese,Ildebrando Appollonio,Lucio Tremolizzo
DOI: https://doi.org/10.3389/frdem.2023.1301280
2023-12-18
Abstract:Behavioral and Psychological Symptoms of Dementia (BPSD) are a heterogeneous set of psychological and behavioral abnormalities seen in persons with dementia (PwD), significantly impacting their quality of life and that of their caregivers. Current assessment tools, such as the Neuropsychiatric Inventory (NPI), are limited by recall bias and lack of direct observation. This study aims to overcome this limitation by making caregiver reports more objective through the use of a novel instrument, referred to as the BPSDiary. This randomized controlled trial will involve 300 caregiver-PwD dyads. The objective is to evaluate whether the use of the BPSDiary could significantly reduce caregiver burden, assessed using the Zarit Burden Interview (ZBI), compared to usual care. The study will include adult PwD, caregivers living with or close to the patient, and BPSD related to the HIDA (hyperactivity, impulsivity, irritability, disinhibition, aggression, agitation) domain. Caregivers randomized to the intervention arm will use the BPSDiary to record specific BPSD, including insomnia, agitation/anxiety, aggression, purposeless motor behavior, and delusions/hallucinations, registering time of onset, severity, and potential triggers. The primary outcome will be the change in ZBI scores at 3 months, with secondary outcomes including changes in NPI scores, olanzapine equivalents, NPI-distress scores related to specific BPSD domains, and caregiver and physician satisfaction. The study will be conducted in 9 Italian centers, representing diverse geographic and sociocultural contexts. While potential limitations include the relatively short observation period and the focus on specific BPSD disturbances, the BPSDiary could provide physicians with objective data to tailor appropriate non-pharmacological and pharmacological interventions. Additionally, it may empower caregivers by encouraging reflection on BPSD triggers, with the potential to improve the quality of life for both PwD and their caregivers. Trial registry: NCT05977855.